Clinical Trials Directory

Trials / Completed

CompletedNCT05013021

Sprint Interval Training on the Endurance, Strength and Velocity Capacities of Healthy Sedentary Subjects

Sprint Interval Training (SIT) on the Endurance, Strength and Velocity Capacities of Healthy Sedentary Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The present study aims to analyse first, the acute effects generated by a single bout of Sprint Interval Training (SIT) and, secondly, the effects of a long-term intervention on sedentary participants.

Detailed description

The main goal is to determine the optimal dose of high-intensity exercise that enhances the best physiological adaptations. The cumulative effects of SIT, will be assessed by a series of measures placed throughout the time-course (before, after the 1st , the 2nd and the 3rd block of SIT). Those measures consist of physiological measurements (VO2max), neuromuscular capacities (force-velocity profile) the autonomic nervous system responses (heart rate variability) and blood markers (lactate, Creatine phosphoKinase (CK), cytokinases, µRNA). Acute effects will be measured in the familiarisation sessions (after short (8 sprints) and long (14 sprints) sets) by performing a battery of neuromuscular, perceptual, and autonomic nervous system tests before and after the single session of SIT.

Conditions

Interventions

TypeNameDescription
OTHERSprint Interval TrainingThe Sprint Interval Training (SIT) training consists of 3 successive blocks of 5 training sessions each. The sessions are 24 to 48 hours apart. . One block lasts two weeks. After the end of one block, the following block begins the day after. The Sprint Interval Training lasts 6 weeks. Each session consists of a series of sprints, the number of which varies from 8 to 14. Thus a session will last from 30 to 45 min approximately So, the time frame of this study is Baseline, Block 1, Block 2 and Block 3 (Not in day or week or month)

Timeline

Start date
2021-09-27
Primary completion
2023-03-08
Completion
2023-03-29
First posted
2021-08-19
Last updated
2023-07-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05013021. Inclusion in this directory is not an endorsement.